Your blood
Normally, your body's bone marrow produces stem cells that grow into different types of blood cells (figure 1). Three types of mature blood cells are:
• Red blood cells (erythrocytes) that carry oxygen from your lungs to all parts of your body. In order to work well, your body needs a constant supply of oxygenated blood.
• Platelets that help your blood clot after a cut or an injury.
• White blood cells (leukocytes) that fight infection and disease.
One kind of white blood cell is a lymphocyte. There are three kinds of lymphocytes:
• B lymphocytes
• T lymphocytes
• Natural killer cells CLL/SLL is caused when the B lymphocytes that come from a single, abnormal cell accumulate. Because of damage to their DNA, the lymphocytes grow in an uncontrolled manner and live longer than normal. This results in a higher than normal concentration of lymphocytes in the blood, bone marrow, lymph nodes and spleen (figures 2a, b) . These abnormal B lymphocytes tend to crowd out other healthy blood cells, preventing them from doing their normal jobs, including fighting infections.
Lymphatic system
The lymphatic system is part of your immune system and is made up of branches that go to lymph nodes all over your body. It drains body fluid (lymph) from the tissues into the veins. The lymph ducts drain lymph through the lymph nodes, which filter germs and other foreign substances. Lymphocytes and other immune system cells circulate continuously through the tissues, lymph nodes and the bone marrow. When you have an infection, the lymphocytes in the lymph nodes respond to fight the infection and prevent further spread of disease. When activated, lymph nodes can swell. Increased lymph node size also can be a sign of malignancy.
Cause/Risk Factors
The cause for CLL/SLL is not known. Although environmental factors have been suspected, there is no scientific proof that the disease is caused by exposure to toxins.
Risk for CLL/SLL can be inherited although most people with CLL do not have a clear family history of leukemia or lymphoma. If you have a family member with CLL/SLL or another kind of lymphocytic malignancy, you may be more likely to get CLL/SLL. Also, people of European descent are more likely to get the disease.
Your risk increases with age. CLL/SLL is never found in children and rarely found in anyone under 40. The average age of diagnosis is 64. Slightly more men than women get the disease.
Diagnosis and Prognosis
CLL/SLL can be hard to diagnose. Most often, people have no symptoms at first, and the disease is found during routine blood tests that show a high lymphocyte count (ALC or absolute lymphocyte count). Today, the diagnosis can be made earlier than in the past because of improved methods to detect the CLL B cells.
If you have a high white blood cell count, further tests need to be done to diagnose CLL/SLL and exclude other forms of chronic leukemia.
If you have symptoms, they may include:
• Fever It is very important to diagnose CLL/SLL accurately. An accurate diagnosis is needed in order to have an idea about the progression of the disease (the prognosis) and the best treatment options.
A complete physical examination with a medical history is done. Blood tests can help to confirm the diagnosis and to provide information about the possible progression of the disease. Blood tests that may be done include:
• CBC (complete blood count). This is needed to measure the effect of the disease on normal blood cell production. By doing a CBC every three to six months, it may be possible to calculate the lymphocyte doubling time (LDT), which measures how long it takes the absolute lymphocyte count (ALC) to double. A shorter LDT (less than one year) seems to be related to a more aggressive disease.
• Flow cytometry examination of blood cells. Usually, this is the standard way to diagnose CLL/SLL. Cells are examined with antibodies, which show if they are malignant and if they have characteristics of CLL/SLL. Levels of cellular proteins, ZAP-70 and CD38, are also examined. High levels of either of these proteins may predict a poorer prognosis. Flow cytometry is available from Mayo Clinic Laboratories as Mayo ID: LCMS / Leukemia/Lymphoma Immunophenotyping by Flow Cytometry. This limited panel, together with the patient history is used to determine what, if any, further testing is needed for disease diagnosis or classification.
• FISH (fluorescence in situ hybridization) panel. This is a way of looking at chromosomal abnormalities (figure 3) that may occur more often in people with CLL/SLL. Some types of abnormalities seem to predict a more aggressive disease course.
• Ig V H (immunoglobulin variable region of the heavy chain) mutation status. Normal B lymphocytes undergo additional mutations (changes) in the gene for their antibody as part of the normal immune response to infection. These mutations increase the effectiveness of the antibodies produced by the body.
In people with CLL/SLL, the abnormal B lymphocytes can be tested for additional mutations. More mutations of the antibody gene over a certain percent may be associated with a better prognosis.
A bone marrow biopsy is not required to diagnose CLL/SLL, but it can provide valuable information about the possible course of CLL in some cases. Bone marrow examination may be done before starting treatment for CLL/SLL. 
Living with CLL/SLL
Being diagnosed with CLL/SLL can be stressful because of the potential seriousness of the disease and the uncertainty about the outcome. Talk to your health care provider about support groups and other resources available to help you and your family cope with a diagnosis of CLL/SLL.
Summary
Although staging is still used to help determine the prognosis of people with CLL/SLL, some of the newer tests discussed above seem to be more useful in predicting the risk of progression in people with early stage disease.
However, some of these tests are not widely available. Look for a medical center with hematologists experienced in the diagnosis and treatment of CLL/SLL.
Treatment
There is currently no cure for CLL/SLL; the goal of treatment is to manage the disease-to ease symptoms and to prolong life. Treatment options depend on the results of the blood tests, the staging of the disease, the symptoms and the overall health of the patient.
Treatment options are changing rapidly. Possible treatments include:
• Observation. If you have no symptoms and tests show that you are at low risk for the disease to progress, you may not need any treatment-at least at first. However, even if you don't need treatment when you are first diagnosed, it is important that you follow the recommendations of your health care provider regarding follow-up. You may need only observation for years if no symptoms develop. Your health care provider also may recommend changes in your lifestyle to promote good health.
• Chemotherapy. Chemotherapy may be one drug or a combination of drugs. Chemotherapy affects the whole body, so a patient can have significant side effects.
• Biological therapy (this includes, but is not restricted to, monoclonal antibody therapy). This is targeted therapy; for example, antibodies target lymphocytes, so treatment may be less toxic and there are fewer side effects than with chemotherapy. Monoclonal antibodies may be combined with chemotherapy. Some recent combinations have shown a better response than the use of chemotherapy alone.
• Hematopoietic stem cell transplant (bone marrow transplant)
is an emerging therapy that may be considered for high-risk patients. It uses chemotherapy and/or radiation therapy along with the infusion of non-embryonic stem cells from a tissue-matched donor. This may act on the leukemia through both the effect of the chemotherapy and/or the radiation therapy and through the effects of the donor cells.
Note on complementary therapy. People often turn to complementary therapies for CLL/SLL. Most of these therapies have not been formally tested, and their effectiveness is unknown. Some complementary therapies can interfere with other medications. To avoid possible toxic reactions, tell your health care provider if you are using any complementary therapy-especially if your CLL is being treated with conventional therapies.
Treatment for CLL/SLL is changing quickly. Effective, innovative treatment depends on an accurate diagnosis of the disease. Clinical trials are constantly going on. If you have questions about treatment or clinical trials, talk with your health care provider.
Healthy Lifestyle
To maximize your quality of life if you have CLL/SLL, your health care provider may recommend certain guidelines for daily living. Healthy approaches to diet, exercise and personal habits may improve long-term survival. If you have questions about activities of daily living, talk with a member of your health care team.
Smoking
Not using tobacco or deciding to stop using it is one of the most important health decisions you can make. Using any type of tobacco-cigarettes, snuff, pipe tobacco or cigars-greatly increases your chance of getting cancer. If you use tobacco, your heart, lungs and blood vessels don't work as well.
Nutrition
Follow a "heart-healthy" diet that includes low to moderate use of fat, sugar and salt and maintain a healthy weight. Maintaining a healthy weight is a lifelong commitment, requiring healthy food choices and exercise. Healthy food choices include the following:
• At least five fruit and vegetable servings each day
• Adequate fiber (whole-grain and enriched cereals, breads and other foods made from whole grain)
• Low-fat or skim milk and low-fat dairy products
• Lean meats, fish and poultry
Alcohol use
Follow the recommendations of your health care team regarding use of alcohol.
Activity
Physical activity may help to keep your body fit. Talk to your health care provider about guidelines for an exercise program.
Hand washing
Hand washing is the most effective way to prevent the spread of infection. Always wash your hands after using the bathroom, before eating and when you handle food. Wash your hands more often if you are sick or if you are around a sick person.
Screening
If you have CLL/SLL, you have an increased risk for other cancers. Follow these guidelines for cancer prevention and screening:
Skin
• Use sunscreen (30 SPF or higher).
• Avoid prolonged sun exposure.
• See a dermatologist about new or changing skin lesions, or as recommended by your health care provider.
Breast
• Do a monthly self-exam.
• Have an annual breast exam by a health care provider.
• Have regular mammograms (either annually after age 40 or as indicated by family history).
Cervical
• Have a Pap smear annually.
Prostate
• Have a digital rectal exam annually.
• Get a PSA (prostate-specific antigen) blood test annually over age 50 unless your health care provider tells you otherwise.
Colon
• Starting at age 50, get a colonoscopy as recommended by your health care provider.
Immunizations
Discuss immunizations with a member of your health care team. Some immunizations are specifically recommended for people who are more susceptible to infections.
Complications
If you have CLL/SLL, you may also have some of the following complications:
• 
Research
Many clinical research studies currently are being done on CLL/SLL. You may be asked to participate in a clinical research study. Researchers design studies to better understand the causes and progression of CLL/SLL and to test the safety and effectiveness of different treatments. Some studies test treatments that have been proven, comparing them to other forms of therapy to see which ones are better.
However, the decision whether or not to take part in a study is entirely up to you. If you are asked to participate in a study, be sure you understand the study's purpose and risks, how long it will last and your responsibilities. Know that you can stop at any time and that your decision-either to participate or not or to stop-in no way affects your medical care.
If you have questions about a study, speak with your health care provider.
